In The News: D-Business Profiles Plans for Exosome Technology by Henry Ford and NeuroTrauma Sciences

July 24, 2018

Detroit business publication D-Business covered the announcement of the new multi-year Sponsored Research and License Agreements between NeuroTrauma Sciences and Henry Ford Health System for the formation of a new company, NeurExo. The company will be dedicated to the development of exosome technology, believed to have therapeutic potential for improving recovery after stroke or other traumatic brain injury. Read the full article here: